pc:moldc

MoldCo

MoldCo is a clinician-led digital health platform focused on standardizing mold detox as a routine aspect of preventative care. The company provides affordable, on-demand expert care, advanced lab testing, and evidence-based treatments for mold-related illnesses through its telehealth platform. MoldCo aims to address the underdiagnosed health crisis of Mold Toxicity by making specialized care accessible and outcomes-driven for patients nationwide. With support from leading tech VCs and renowned physicians, MoldCo is committed to integrating mold detox into routine health practices, enhancing public and physician awareness, and expanding its services across the United States.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―

Estimated Valuation―

Total Amount Raised$8M

Total Amount Raised$8M

Total Funding Rounds1

Total Funding Rounds1

Latest Funding Amount$8M

Latest Funding Amount$8M

Latest Funding RoundSeed Round

Latest Funding RoundSeed Round

Post-Money Valuation―

Post-Money Valuation―

Funding Round

Sep 18, 2025

Seed Round

$8.00M

―

Investors

Collaborative Fund

Seed Round

Seed Round

Related News and Analysis

Flexzo Ai Signs Multi-Year Deal to Power Island Doctors’ AI-Driven Staffing Across Florida Clinics

Flexzo Ai Signs Multi-Year Deal to Power Island Doctors’ AI-Driven Staffing Across Florida Clinics

New updates have been reported about Flexzo AI. Flexzo Ai has secured a multi-year, multi-site agreement to deploy...

1d ago

Flexzo Ai Wins Nao Medical Deal to Power Data-Driven Clinician Hiring and Deployment

Flexzo Ai Wins Nao Medical Deal to Power Data-Driven Clinician Hiring and Deployment

New updates have been reported about Flexzo AI. Flexzo Ai has secured a strategic partnership with Nao Medical,...

1d ago

AG1 Backs Penn State Research on Nutrition and GLP-1 Medication Use

AG1 Backs Penn State Research on Nutrition and GLP-1 Medication Use

According to a recent LinkedIn post from AG1, the company is highlighting rapid growth in GLP-1 medication use...

1d ago

Harvey Expands APAC Presence With Singapore Office and Legal-Sector Engagement

Harvey Expands APAC Presence With Singapore Office and Legal-Sector Engagement

According to a recent LinkedIn post from Harvey, the company is building momentum across the Asia-Pacific region, with...

1d ago

Apono Highlights Zero-Standing-Privilege Focus Ahead of RSA 2026

Apono Highlights Zero-Standing-Privilege Focus Ahead of RSA 2026

According to a recent LinkedIn post from Apono, the company is promoting its presence at the RSA 2026...

1d ago

Sakana AI Expands Focus on Defense and Intelligence Analytics With Narrative-Extraction Technology

Sakana AI Expands Focus on Defense and Intelligence Analytics With Narrative-Extraction Technology

According to a recent LinkedIn post from Sakana AI, the company collaborated with Yomiuri Shimbun to analyze China-originated...

1d ago

Simpro Software Highlights AI-Driven Focus on Review Management for Contractors

Simpro Software Highlights AI-Driven Focus on Review Management for Contractors

A LinkedIn post from Simpro Software highlights an upcoming webinar focused on how online reviews influence commercial contracting...

1d ago

ConverzAI Targets Staffing Industry Decision Makers With Agentic AI Positioning

ConverzAI Targets Staffing Industry Decision Makers With Agentic AI Positioning

A LinkedIn post from ConverzAI highlights the participation of CEO and founder Ashwarya Poddar in an interactive roundtable...

1d ago

GMI Cloud Hosts Singapore AI DevHack to Build Developer Ecosystem

GMI Cloud Hosts Singapore AI DevHack to Build Developer Ecosystem

According to a recent LinkedIn post from GMI Cloud, the company is organizing a one-day DevHack event in...

1d ago

Replit Targets Developer Growth With Agent 4 Buildathon Initiative

Replit Targets Developer Growth With Agent 4 Buildathon Initiative

According to a recent LinkedIn post from Replit, the company is promoting an “Agent 4 Buildathon,” a three-week...

1d ago